NEW DELHI: Jubilant Biosys, the Bangalore-based research subsidiary of Jubilant Organosys has developed a screening solution to accelerate drug discovery programme, a company release said. The new software allows scientists to capture, store and analyse Oracle 9i/10g based screening data with greater flexibility, accuracy and speed.

It has been developed in collaboration with a leading global drug company whose name has not been disclosed. The software is available through subscription and will be initially launched in the US and Europe, the company added.

This novel screening tool for scientific, pharmaceutical and biotech communities around the world can enhance the productivity of pharmaceutical and biotech research, Jubilant Biosys, head IT Amit Rustagi said.